je.st
news
Home
›
Luminex Corporation Announces Group B Streptococcus (GBS), as a Launch Menu Assay for Its New ...
Luminex Corporation Announces Group B Streptococcus (GBS), as a Launch Menu Assay for Its New ...
2014-05-12 06:00:00| Industrial Newsroom - All News for Today
AUSTIN, Texas - Luminex Corporation (NASDAQ: LMNX) today announced that Group B Streptococcus (group B strep, GBS) is the fifth assay planned for the launch menu of its new sample-to-answer system, ARIES™. The assay will complement Luminex's growing portfolio of ASR and IVD products. Previously announced items in the five assay launch menu targeted for the ARIES system include: Flu A/B and RSV, HSV 1&2, Norovirus, and Clostridium difficile (C. diff).<br /> <br /> "ARIES represents the ...This story is related to the following:Test and Measuring InstrumentsSample Conditioning Equipment | Laboratory Equipment & Supplies
Tags: for
new
its
group
Category:Industrial Goods and Services
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||